RECITALSProduct Option Agreement • May 6th, 1998 • Clinichem Development Inc • Pharmaceutical preparations • Quebec
PRODUCT OPTION AGREEMENTProduct Option Agreement • February 18th, 2011 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
This PRODUCT OPTION AGREEMENT (“Agreement”) is made and entered into as of the latest date set forth on the signature lines below (the “Effective Date”), by and between Oculus Innovative Sciences, Inc., a Delaware corporation having a place of business at 1129 North McDowell Boulevard, Petaluma, California 94954 (“OCULUS”); and AmDerma Pharmaceuticals, LLC, a Delaware limited liability company having a place of business at 440 US Highway 22 East, Suite 104, Bridgewater, New Jersey 08807 (“AmDerma”).
